Warburg Pincus related stories
All articles and analysis
US VC stays strong despite few IPOsNew data from the National Venture Capital Association shows that long-term performance in the US remains strong despite dismal IPO valuation. Dave Keating reports.
- SEP launches Fund III with £120m
The Scottish investor has raised £120m for its third venture capital fund, although no final target size has yet been decided.
- Warburg cashes out of Czech pharma business
The global investor has generated around $1.2bn in total from its investment in pharmaceutical group Zentiva, which it acquired in 1998.
- Report: Harbin syndication falters
The syndication of a $282m leveraged loan connected to a private equity investment in China’s Harbin Pharmaceutical appears to be struggling to attract support.
- Albertson’s sold for $17.4bn
In a major buyout deal involving no buyout firms, Albertson’s agreed to a sale valued at $17.4bn, with SuperValu, CVS and Cerberus Capital Management teaming up to buy the US supermarket and drug-store chain.
- PE firms eye Shanghai Pharma
One of China’s largest pharmaceutical groups is attracting interest from private equity firms after reportedly announcing that it wants to sell a large stake to foreign buyers.
- GSC, Tishman in real estate JV
GSC Partners and Tishman Speyer have launched a Chinese real estate joint venture, marking GSC’s first move into real estate.
- KKR eyes Asia
In the same week that Blackstone announced plans to open an office in India, KKR is reportedly considering its first Asian investment – an $800m stake in Samsung Life Assurance.
- Distress down under
A recent high-profile distressed deal in Australia sees the retail trend hit the Southern Hemisphere. By Aaron Lovell.
- NGP amasses $1.7bn over three funds
NGP Energy Capital Management announced the close of three funds, which combined took in $1.7 billion in limited partner commitments.